Is Celestica The Best AI Stock to Buy Now?
Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…
Sell
32
AGEN Quote, Financials, Valuation and Earnings
Last price:
$3.29
Seasonality move
:
-3.26%
Day range:
$3.14 - $3.38
52-week range:
$1.38 - $7.34
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.85x
P/B ratio:
--
Volume:
204.3K
Avg. volume:
650.1K
1-year change:
7.35%
Market cap:
$121.4M
Revenue:
$103.5M
EPS (TTM):
-$2.13
Analysts' Opinion
-
Consensus RatingAgenus, Inc. has received a consensus rating of Buy. The company's average rating is a Buy based on 2 Buy ratings, 1 Hold rating, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $12.33, Agenus, Inc. has an estimated upside of 267.06% from its current price of $3.36.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $6.00 representing 100% downside risk from its current price of $3.36.
Fair Value
-
According to the consensus of 3 analysts, Agenus, Inc. has 267.06% upside to fair value with a price target of $12.33 per share.
AGEN vs. S&P 500
-
Over the past 5 trading days, Agenus, Inc. has overperformed the S&P 500 by 4.68% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Agenus, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Agenus, Inc. has grown year-over-year revenues for 2 quarters straight. In the most recent quarter Agenus, Inc. reported revenues of $30.2M.
Earnings Growth
-
Agenus, Inc. has grown year-over-year earnings for 9 quarters straight. In the most recent quarter Agenus, Inc. reported earnings per share of $1.94.
Enterprise value:
452.2M
EV / Invested capital:
--
Price / LTM sales:
0.85x
EV / EBIT:
--
EV / Revenue:
4.23x
PEG ratio (5yr expected):
0.00x
EV / Free cash flow:
-5.06x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$93M
Return On Assets:
-18.12%
Net Income Margin (TTM):
-36.77%
Return On Equity:
--
Return On Invested Capital:
-39.69%
Operating Margin:
-16.08%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $100.9M | $160.4M | $106.8M | $25.1M | $30.2M | |
| Gross Profit | $80.1M | $144.5M | $93M | $21.6M | $26.6M | |
| Operating Income | -$213.4M | -$100.8M | -$62.9M | -$33.4M | -$4.9M | |
| EBITDA | -$203.1M | -$85.5M | -$50.3M | -$30M | -$1.8M | |
| Diluted EPS | -$16.33 | -$11.00 | -$2.13 | -$3.08 | $1.94 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $308.4M | $251.4M | $125.6M | $50.2M | $134M | |
| Total Assets | $437.6M | $429M | $335.5M | $238.5M | $233.9M | |
| Current Liabilities | $150.1M | $173.1M | $198.4M | $270.6M | $287.1M | |
| Total Liabilities | $402.1M | $440.9M | $450.8M | $510.3M | $514.8M | |
| Total Equity | $35.6M | -$11.8M | -$115.3M | -$271.8M | -$280.9M | |
| Total Debt | $307.5M | $348.5M | $352M | $418.2M | $339.8M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$231.1M | -$170.1M | -$89.2M | -$53.3M | -$14.7M | |
| Cash From Investing | -$5.8M | $2.9M | $393K | $56K | $76K | |
| Cash From Financing | $136.3M | $105.8M | $45.6M | $4.6M | $6.7M | |
| Free Cash Flow | -$260.6M | -$165.4M | -$89.3M | -$53.3M | -$14.7M | |
AGEN
Sector
Market Cap
$121.4M
$25.8M
Price % of 52-Week High
45.78%
50.24%
Dividend Yield
0%
0%
Shareholder Yield
-16.31%
-1.64%
1-Year Price Total Return
7.35%
-18.88%
Beta (5-Year)
1.619
0.496
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$3.16
200-day SMA
Sell
Level
$4.24
Bollinger Bands (100)
Sell
Level
3.22 - 4.24
Chaikin Money Flow
Sell
Level
-627.1M
20-day SMA
Buy
Level
$3.01
Relative Strength Index (RSI14)
Buy
Level
56.53
ADX Line
Buy
Level
17.51
Williams %R
Sell
Level
-2.4194
50-day SMA
Buy
Level
$3.34
MACD (12, 26)
Sell
Level
-0.04
25-day Aroon Oscillator
Sell
Level
-40
On Balance Volume
Neutral
Level
259.2M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-15.7231)
Sell
CA Score
(Annual)
Level (-8.8244)
Buy
Beneish M-Score
(Annual)
Level (-5.3046)
Buy
Momentum Score
Level (7)
Sell
Ohlson Score
Level (16.7741)
Sell
Piotroski F Score
(Annual)
Level (2)
Buy
Quality Ratio Score
Level (8)
Sell
Fundamental Score
Level (2)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Agenus, Inc. is a clinical-stage company, which engages in the development and commercialization of technologies to treat cancers and infectious diseases. Its product pipeline includes Balstilimab, Zalifrelimab, AGEN1181, AGEN1327, AGEN2373, AGENt-797 and AGEN1777. The company was founded by Garo H. Armen and Pramod K. Srivastava on March 31, 1994 and is headquartered in Lexington, MA.
Stock Forecast FAQ
In the current month, AGEN has received 2 Buy ratings 1 Hold ratings, and 0 Sell ratings. The AGEN average analyst price target in the past 3 months is $12.33.
-
Where Will Agenus, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Agenus, Inc. share price will rise to $12.33 per share over the next 12 months.
-
What Do Analysts Say About Agenus, Inc.?
Analysts are divided on their view about Agenus, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Agenus, Inc. is a Sell and believe this share price will drop from its current level to $6.00.
-
What Is Agenus, Inc.'s Price Target?
The price target for Agenus, Inc. over the next 1-year time period is forecast to be $12.33 according to 3 Wall Street analysts, 2 of them rate the stock a Buy, 0 rate the stock a Sell, and 1 analyst rates the stock a Hold.
-
Is AGEN A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Agenus, Inc. is a Buy. 2 of 3 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of AGEN?
You can purchase shares of Agenus, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Agenus, Inc. shares.
-
What Is The Agenus, Inc. Share Price Today?
Agenus, Inc. was last trading at $3.29 per share. This represents the most recent stock quote for Agenus, Inc.. Yesterday, Agenus, Inc. closed at $3.36 per share.
-
How To Buy Agenus, Inc. Stock Online?
In order to purchase Agenus, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Related Companies
Get AGEN Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
AGEN
Sector
P/E ratio
--
23.44x
PEG ratio
0.00x
-0.01x
P/B ratio
--
1.81x
Price / LTM sales
0.85x
1.56x
Growth Metrics
AGEN
Sector
Revenue growth
20.4%
3.27%
Earnings growth
163.04%
9.66%
Revenue (5-year growth)
-7.17%
6.43%
Earnings forecast
-$1.30
-$0.20
Profitability
AGEN
Sector
Profitability FY 2024
$89.6M
$2.3M
Return on invested capital
-39.69%
-33.49%
Return on assets
-18.12%
-29.74%
Return on equity
--
-39.33%
Earnings Date
Last Earnings Date
Nov
10
Next Earnings Date
Mar
10
Estimated Next Earnings Date
Feb
9
Balance Sheet
AGEN
Sector
Total cash
$3.5M
$24.2M
Short term investments
--
$23.8M
Total assets
$226.3M
$71.1M
Long term debt
$339.8M
$2.5M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will AI Disrupt SaaS Software Stocks?
Since January 28th, software stocks in the United States have…
Why Is Meta Stock Going Higher?
Over the last five days, shares of Instagram and Facebook…
Stock Ideas
Sell
50
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 38x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Sell
37
Is GOOGL Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 28x
Alerts
Buy
59
SEZL alert for Feb 27
Sezzle, Inc. [SEZL] is down 14.29% over the past day.
Buy
83
GCT alert for Feb 27
GigaCloud Technology, Inc. [GCT] is down 7.51% over the past day.
Buy
62
LMAT alert for Feb 27
LeMaitre Vascular, Inc. [LMAT] is down 5.73% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
